The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
from NYT > Business https://ift.tt/l37eWpB
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
By -Ahmed
October 03, 2024
0
Post a Comment
0Comments